BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11550574)

  • 1. [Effect of tactivin in vitro on lymphocytes from patients with acute hepatitis B].
    Ryndina EI
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):93-4. PubMed ID: 11550574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An in-vitro system study of the immunomodulating activity of taktivin in atopic dermatitis].
    Matushevskaia EV; Skriabina EG; Kubanova AA; Balo-Banga M
    Vestn Dermatol Venerol; 1990; (9):9-11. PubMed ID: 2284871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restoration by T-activin and its subfractions of splenocyte membrane structures in thymectomized animals].
    Arion VIa; Moshkovskaia EIu; Azizova OA; Zimina IV
    Biull Eksp Biol Med; 1990 Jul; 110(7):53-6. PubMed ID: 2224102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tactivin on cytotoxicity of blood lymphocytes in chronic myeloproliferative diseases].
    Guseva SA
    Gematol Transfuziol; 1994; 39(5):22-5. PubMed ID: 7896025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the action of taktivin on different stages of T-lymphocyte maturation].
    Mikhna MG; Miroshnichenko IV; Nikonova MF; Aknazarova RKh; Iarilin AA
    Biull Eksp Biol Med; 1988 Feb; 105(2):189-91. PubMed ID: 2894867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution in mice of 125I-monoclonal antibodies to T-lymphocyte antigen Ly 2.1 under the influence of immunomodulators].
    Miroliubova OIu; Fadeev NP; Serzhanina VA; Klimovich VB; Makarenko MV; Korsakova LN
    Med Radiol (Mosk); 1991; 36(5):8-10. PubMed ID: 2034116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the blood immunological indices of newborn infants as affected by T-activin in vitro].
    Samsygin SA; Dolgina EN; Arion VIa; Baryshkov IuN; Breusov IuN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):45-8. PubMed ID: 3499729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tactivin on the behaviour and learning in rats].
    Kiseleva NM; Novoseletskaia AV; Zimina IV; Moskvina SN; Inozemtsev AN; Arion VIa; Lopukhin IuM
    Vestn Ross Akad Med Nauk; 2010; (1):23-6. PubMed ID: 20408435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thymic factor tactivin prevents ACTH from stimulating steroidogenesis by mouse adrenal cells.
    Chesnokova VM; Ignatjeva EV; Ivanova LN
    Thymus; 1992 Mar; 19(2):65-75. PubMed ID: 1313998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymostimulin as an immunomodulator in gynaecological oncology.
    Corradi G; Cappello F; Cappellari A; Bagarella M; Olivati S; Martinelli D; Zago L
    Biomed Pharmacother; 1985; 39(8):448-9. PubMed ID: 3879665
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunocorrective therapy of pyelonephritis in children].
    Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
    Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid system is involved in the analgesic effects of Tactivin.
    Inozemtsev AN; Novoseletskaya AV; Matveeva OD; Aristova VV; Kalyuzhnyi AL; Shulgovskii VV; Zimina IV; Arion VY
    Dokl Biol Sci; 2013 May; 450():130-3. PubMed ID: 23821049
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunogenetic indicators in protracted hepatitis and their dynamics during the treatment with T-activin].
    Stanevicha VA; Veksler KhM
    Pediatriia; 1991; (10):44-8. PubMed ID: 1787998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dose dependence of various loads using the rosette formation method].
    Gladysheva TB; Konradov AA; Lebedev KA
    Biofizika; 1989; 34(5):833-4. PubMed ID: 2611281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro reactivity of lymphocytes after the addition of immunostimulatory drugs].
    Vucković-Dekić L; Stanojević-Bakić N; Radosavljević D; Rajner L; Dekić M
    Srp Arh Celok Lek; 1995; 123(3-4):81-2. PubMed ID: 16296229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined detoxification and immunocorrective therapy in patients with peritonitis].
    Shkrob LO; Fedotov PA; Ermakova NG
    Khirurgiia (Mosk); 1994 Mar; (3):20-2. PubMed ID: 8007606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases.
    Incefy GS; Boumsell L; Kagan W; Goldstein G; Sousa MD; Smithwick E; O'Reilly R; Good RA
    Trans Assoc Am Physicians; 1975; 88():135-45. PubMed ID: 772925
    [No Abstract]   [Full Text] [Related]  

  • 19. [The plasma fibronectin content and its significance in patients with bronchial asthma].
    Vassim K; Bratchik AM; Zorin VM; Dovgan' AA
    Lik Sprava; 1992 Jan; (1):64-6. PubMed ID: 1364611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of 3 different thymus extracts on T lymphocytes from patients with lymphoma and solid tumors in the advanced phase].
    Ogier C; Moratelli S; Ballerini G
    Riv Emoter Immunoematol; 1983; 30(1):56-61. PubMed ID: 6605568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.